2.4435
price down icon0.41%   -0.0065
 
loading
전일 마감가:
$2.45
열려 있는:
$2.46
하루 거래량:
950.63K
Relative Volume:
0.10
시가총액:
$2.31B
수익:
$1.31M
순이익/손실:
$-597.65M
주가수익비율:
-2.5191
EPS:
-0.97
순현금흐름:
$-425.62M
1주 성능:
-2.79%
1개월 성능:
-10.62%
6개월 성능:
-2.79%
1년 성능:
-31.27%
1일 변동 폭
Value
$2.42
$2.47
1주일 범위
Value
$2.40
$2.67
52주 변동 폭
Value
$1.83
$7.48

Immunitybio Inc Stock (IBRX) Company Profile

Name
명칭
Immunitybio Inc
Name
전화
(844) 696-5235
Name
주소
3530 JOHN HOPKINS COURT, SAN DIEGO
Name
직원
685
Name
트위터
Name
다음 수익 날짜
2024-11-06
Name
최신 SEC 제출 서류
Name
IBRX's Discussions on Twitter

IBRX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
IBRX
Immunitybio Inc
2.4401 2.32B 1.31M -597.65M -425.62M -0.97
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
419.16 107.45B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
475.87 64.39B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
576.75 61.13B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
839.57 52.30B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
165.12 35.49B 398.11M -1.03B -868.57M -5.7032

Immunitybio Inc Stock (IBRX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-05-20 업그레이드 Piper Sandler Neutral → Overweight
2025-03-06 개시 H.C. Wainwright Buy
2025-01-10 개시 BTIG Research Buy
2023-05-12 다운그레이드 Piper Sandler Overweight → Neutral
2022-08-03 개시 Jefferies Buy

Immunitybio Inc 주식(IBRX)의 최신 뉴스

pulisher
Oct 20, 2025

Applying big data sentiment scoring on ImmunityBio Inc.Trade Signal Summary & Entry Point Strategy Guides - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Why ImmunityBio Inc. (26CA) stock benefits from AI revolutionTrade Ideas & High Accuracy Swing Entry Alerts - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Published on: 2025-10-20 12:10:55 - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

ImmunityBio Inc. stock trend outlook and recovery pathLong Setup & Free Growth Oriented Trading Recommendations - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Why ImmunityBio Inc. (26CA) stock is a strong analyst pickShare Buyback & Community Consensus Trade Alerts - newser.com

Oct 20, 2025
pulisher
Oct 19, 2025

Tick level data insight on ImmunityBio Inc. volatilityQuarterly Trade Report & Precise Buy Zone Tips - newser.com

Oct 19, 2025
pulisher
Oct 18, 2025

Will ImmunityBio Inc. stock outperform tech sector in 2025Market Sentiment Report & Technical Entry and Exit Alerts - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

Short interest data insights for ImmunityBio Inc.Trade Entry Report & Fast Moving Trade Plans - newser.com

Oct 18, 2025
pulisher
Oct 18, 2025

Is ImmunityBio Inc. stock a buy on dipsWeekly Earnings Recap & Weekly Return Optimization Alerts - newser.com

Oct 18, 2025
pulisher
Oct 18, 2025

Will ImmunityBio Inc. stock split again soon2025 Trading Volume Trends & Technical Entry and Exit Tips - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

How ImmunityBio Inc. stock reacts to job market data2025 Market Trends & Weekly Market Pulse Alerts - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 17, 2025

Can machine learning forecast ImmunityBio Inc. recovery2025 Trading Recap & Real-Time Chart Pattern Alerts - newser.com

Oct 17, 2025
pulisher
Oct 17, 2025

Institution Moves: Will ImmunityBio Inc. stock outperform tech sector in 20252025 Support & Resistance & Stepwise Swing Trade Plans - nchmf.gov.vn

Oct 17, 2025
pulisher
Oct 17, 2025

Discover ImmunityBio And Two Other Growth Stocks With High Insider Ownership - simplywall.st

Oct 17, 2025
pulisher
Oct 16, 2025

Is ImmunityBio Inc a good long term investmentResistance Breakout Alerts & Unlock Free Weekly Portfolio Checkups - earlytimes.in

Oct 16, 2025
pulisher
Oct 15, 2025

Will ImmunityBio Inc. stock benefit from infrastructure spendingJuly 2025 EndofMonth & Risk Controlled Stock Alerts - newser.com

Oct 15, 2025
pulisher
Oct 13, 2025

Will ImmunityBio Inc. rebound enough to break evenBear Alert & Community Consensus Picks - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

How to recover losses in ImmunityBio Inc. stockJuly 2025 Rallies & Long-Term Investment Growth Plans - newser.com

Oct 13, 2025
pulisher
Oct 11, 2025

Published on: 2025-10-11 12:10:43 - earlytimes.in

Oct 11, 2025
pulisher
Oct 11, 2025

ImmunityBio, Inc.Common Stock (NQ: IBRX - FinancialContent

Oct 11, 2025
pulisher
Oct 11, 2025

Why Immunitybio Inc. (IBRX) Soared on Thursday - MSN

Oct 11, 2025
pulisher
Oct 10, 2025

ImmunityBio, Inc. (IBRX) Reports Strong Q2 Growth, Eyes Lung Cancer and NMIBC Expansion - MSN

Oct 10, 2025
pulisher
Oct 10, 2025

ImmunityBio, Inc. (26CA.F) stock price, news, quote and history - Yahoo

Oct 10, 2025
pulisher
Oct 09, 2025

Will EnGene Join The Ranks Of Merck, Ferring, And ImmunityBio In Bladder Cancer Treatment? - RTTNews

Oct 09, 2025
pulisher
Oct 08, 2025

IBRX stockholders via consent approve 1.65B common share authorization - Stock Titan

Oct 08, 2025
pulisher
Oct 06, 2025

Real time social sentiment graph for ImmunityBio Inc.2025 Pullback Review & Accurate Intraday Trading Signals - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Evaluating ImmunityBio Inc. with trendline analysis2025 Major Catalysts & Growth Oriented Trading Recommendations - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Is ImmunityBio Inc. (26CA) stock prepared for digital transitionJuly 2025 Technicals & Smart Allocation Stock Tips - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

ImmunityBio Inc. stock retracement – recovery analysis2025 Investor Takeaways & AI Enhanced Trading Signals - newser.com

Oct 05, 2025
pulisher
Oct 04, 2025

ANKTIVA Reimbursement Gains and UK Approval Might Change The Case For Investing In ImmunityBio (IBRX) - Sahm

Oct 04, 2025
pulisher
Oct 03, 2025

ImmunityBio, Inc. (NASDAQ:IBRX) Given Average Recommendation of "Buy" by Brokerages - MarketBeat

Oct 03, 2025
pulisher
Oct 03, 2025

What Went Wrong With ImmunityBio’s Executives Claims — and How Investors Could Still Win - TradingView

Oct 03, 2025
pulisher
Oct 03, 2025

ImmunityBio: A Small Bet Is Warranted (NASDAQ:IBRX) - Seeking Alpha

Oct 03, 2025
pulisher
Oct 03, 2025

NMIBC Market to Experience Notable Growth in Forecast Span - openPR.com

Oct 03, 2025

Immunitybio Inc (IBRX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$36.82
price up icon 0.33%
$86.60
price up icon 0.48%
$29.77
price down icon 2.54%
$107.39
price down icon 0.53%
biotechnology ONC
$317.08
price down icon 0.61%
$165.58
price down icon 1.44%
자본화:     |  볼륨(24시간):